MX376386B - Composiciones para usarse en el tratamiento de patologías del tejido de cartílago y disco. - Google Patents

Composiciones para usarse en el tratamiento de patologías del tejido de cartílago y disco.

Info

Publication number
MX376386B
MX376386B MX2016002556A MX2016002556A MX376386B MX 376386 B MX376386 B MX 376386B MX 2016002556 A MX2016002556 A MX 2016002556A MX 2016002556 A MX2016002556 A MX 2016002556A MX 376386 B MX376386 B MX 376386B
Authority
MX
Mexico
Prior art keywords
sub
cartilage
compositions
treatment
disc tissue
Prior art date
Application number
MX2016002556A
Other languages
English (en)
Other versions
MX2016002556A (es
Inventor
Fackson Mwale
John Antoniou
Laura M Epure
Lisbet Haglund
Michael P Grant
Peter J Roughley
Rahul Gawri
Original Assignee
The Royal Institution For The Advancement Of Learning/Mcgill Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Royal Institution For The Advancement Of Learning/Mcgill Univ filed Critical The Royal Institution For The Advancement Of Learning/Mcgill Univ
Publication of MX2016002556A publication Critical patent/MX2016002556A/es
Publication of MX376386B publication Critical patent/MX376386B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Wood Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un polipéptido aislado que comprende un péptido seleccionado de: i) DHX1SDNYT, en donde X1 es L o H (SEQ ID NO:3); ii) una variante conservadora de i); iii) un fragmento de i) o ii); donde la variante conservadora y/o fragmento retiene la actividad biológica y el péptido tiene 15 o menos aminoácidos así como células recombinantes, y sus usos.
MX2016002556A 2013-08-27 2014-08-27 Composiciones para usarse en el tratamiento de patologías del tejido de cartílago y disco. MX376386B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361870394P 2013-08-27 2013-08-27
US201461975329P 2014-04-04 2014-04-04
PCT/CA2014/000656 WO2015027322A1 (en) 2013-08-27 2014-08-27 Methods and compositions for treatment of cartilage and disc tissue pathologies

Publications (2)

Publication Number Publication Date
MX2016002556A MX2016002556A (es) 2016-10-26
MX376386B true MX376386B (es) 2025-03-07

Family

ID=52585327

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016002556A MX376386B (es) 2013-08-27 2014-08-27 Composiciones para usarse en el tratamiento de patologías del tejido de cartílago y disco.

Country Status (12)

Country Link
US (3) US10202420B2 (es)
EP (1) EP3039032B1 (es)
JP (1) JP6700182B2 (es)
KR (1) KR102369010B1 (es)
CN (1) CN105940011B (es)
AU (2) AU2014311219B2 (es)
CA (1) CA2957965C (es)
ES (1) ES2883567T3 (es)
IL (1) IL244282B (es)
MX (1) MX376386B (es)
WO (1) WO2015027322A1 (es)
ZA (1) ZA201601963B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6700182B2 (ja) 2013-08-27 2020-05-27 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 軟骨及び椎間板組織病理の治療のためのポリペプチド及び組成物
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443147A1 (en) * 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
WO2002083920A2 (en) * 2001-04-10 2002-10-24 Agensys, Inc. Nucleic acid sequences useful in the detection and treatment of various cancers
JP6700182B2 (ja) * 2013-08-27 2020-05-27 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング／マギル ユニバーシティ 軟骨及び椎間板組織病理の治療のためのポリペプチド及び組成物

Also Published As

Publication number Publication date
JP6700182B2 (ja) 2020-05-27
CA2957965C (en) 2023-03-28
JP2016534117A (ja) 2016-11-04
AU2014311219A1 (en) 2016-04-21
KR20160058109A (ko) 2016-05-24
WO2015027322A1 (en) 2015-03-05
US20160207959A1 (en) 2016-07-21
US10202420B2 (en) 2019-02-12
KR102369010B1 (ko) 2022-03-02
US20190375788A1 (en) 2019-12-12
AU2019201512A1 (en) 2019-03-28
IL244282A0 (en) 2016-04-21
EP3039032B1 (en) 2021-05-19
MX2016002556A (es) 2016-10-26
ES2883567T3 (es) 2021-12-09
AU2014311219B2 (en) 2018-12-06
EP3039032A1 (en) 2016-07-06
ZA201601963B (en) 2022-08-31
IL244282B (en) 2021-09-30
CN105940011B (zh) 2021-01-05
EP3039032A4 (en) 2017-04-19
US20210079040A1 (en) 2021-03-18
CA2957965A1 (en) 2015-03-05
CN105940011A (zh) 2016-09-14

Similar Documents

Publication Publication Date Title
ES2545895T3 (es) Proteína de fusión anticancerígena
EA201190326A1 (ru) Полипептиды гормона роста и способы их получения и применения
ES2513716T3 (es) Enzimas lecitina-colesteros acitransferasa modificadas
CO2018005306A2 (es) Variantes del factor viii reducido con cpg, composiciones y métodos y usos para el tratamiento de trastornos de la hemostasia
PE20160507A1 (es) Diferenciacion de celulas madre mesenquimales
ES2691070T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
MX339277B (es) Agente inductor de inmunidad.
ES2693321T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
NZ707439A (en) Modified factor ix polypeptides and uses thereof
ES2565060T3 (es) Polipéptidos que tienen actividad de glucoamilasa y polinucleótidos que codifican los mismos
PE20181206A1 (es) Construcciones especificas del higado, casetes de expresion del factor viii y metodos de uso de estos
EA201170993A1 (ru) Удлиненные рекомбинантные полипептиды и содержащие их композиции
MY188897A (en) Factor viii compositions and methods of making and using same
AR086214A1 (es) Composiciones detergentes que contienen mananasa de bacillus agaradhaerens y sus metodos de uso
ES2694667T3 (es) Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato
EA201401211A1 (ru) Улучшенные варианты фермента химозина
IN2012DN02981A (es)
EP2589658A4 (en) PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN
NZ610620A (en) Inhibitors of apoptosis and uses thereof
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
CR20150196A (es) Moléculas de unión il-17a novedosas y usos médicos de las mismas
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
AR073810A1 (es) Polipeptidos que tienen actividad antimicrobiana
AR090636A1 (es) Mutacion del motivo ear de polipeptidos de hd-zip de clase ii
PE20211303A1 (es) Polipeptidos del factor vii de accion corta

Legal Events

Date Code Title Description
FG Grant or registration